JNJ - JOHNSON & JOHNSON
Close
166.2
0 0%
Share volume: 0
Last Updated: Fri 20 Dec 2024 09:00:07 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.51%
PREVIOUS CLOSE
CHG
CHG%
$166.20
-23.24
0.16%
Fundamental analysis
71%
Profitability
81%
Dept financing
36%
Liquidity
70%
Performance
70%
Performance
5 Days
-1.33%
1 Month
-6.90%
3 Months
-11.49%
6 Months
-3.12%
1 Year
-7.07%
2 Year
-18.39%
Key data
Stock price
$166.20
DAY RANGE
$142.96 - $166.20
52 WEEK RANGE
$145.22 - $168.85
52 WEEK CHANGE
-$7.07
DIVIDEND
$1.24
EX-DIVIDEND DATE
08/27/2024
NEXT EARNINGS DATE
10/15/2024
Company detail
CEO: Joaquin Duato
Region: US
Website: jnj.com
Employees: 152,700
IPO year: -
Issue type: Common Stock
Market: NYSE
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: jnj.com
Employees: 152,700
IPO year: -
Issue type: Common Stock
Market: NYSE
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands. Pharmaceutical segment offers products for rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis. MedTech segment provides electrophysiology products to treat cardiovascular diseases.
Recent news